Blockades of ATP-sensitive potassium channels and L-type calcium channels improve analgesic effect of morphine in alloxan-induced diabetic mice

Pathophysiology

Volumn 19, Issue 3, 2012, Pages 171-177

  Ahmadi, Shamseddin ^a   Ebrahimi, Sayede Shohre ^b   Oryan, Shahrbanoo ^b   Rafieenia, Fatemeh ^a  

^a UNIVERSITY OF KURDISTAN   (Iran)

^b KHARAZMI UNIVERSITY   (Iran)

Author keywords

Alloxan; Analgesia; Diabetes; Glibenclamide; Morphine; Nimodipine

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ALLOXAN; CALCIUM CHANNEL L TYPE; GLIBENCLAMIDE; GLUCOSE; MORPHINE; NIMODIPINE;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; GLUCOSE BLOOD LEVEL; HOT PLATE TEST; LATENT PERIOD; MALE; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; TREATMENT RESPONSE;

EID: 84865415334     PISSN: 09284680     EISSN: 1873149X     Source Type: Journal    
DOI: 10.1016/j.pathophys.2012.04.007     Document Type: Article

References (35)

1. Somogyi A.A., Barratt D.T., Coller J.K. Pharmacogenetics of opioids. Clinical Pharmacology and Therapeutics 2007, 81:429-444.
2. Cunha T.M., Roman-Campos D., Lotufo C.M., Duarte H.L., Souza G.R., Verri W.A., et al. Morphine peripheral analgesia depends on activation of the PI3Kgamma/AKT/nNOS/NO/KATP signaling pathway. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:4442-4447.
3. Nestler E.J. Molecular mechanisms of drug addiction. Neuropharmacology 2004, 47(Suppl. 1):24-32.
4. Rodrigues A.R., Duarte I.D. The peripheral antinociceptive effect induced by morphine is associated with ATP-sensitive K(+) channels. British Journal of Pharmacology 2000, 129:110-114.
5. + channels and cellular actions of morphine in periaqueductal gray slices of neonatal and adult rats. Journal of Pharmacology and Experimental Therapeutics 2001, 298:493-500.
6. Benedek G., Szikszay M. Potentiation of thermoregulatory and analgesic effects of morphine by calcium antagonists. Pharmacological Research Communications 1984, 16:1009-1018.
7. Contreras E., Tamayo L., Amigo M. Calcium channel antagonists increase morphine-induced analgesia and antagonize morphine tolerance. European Journal of Pharmacology 1988, 148:463-466.
8. Del Pozo E., Caro G., Baeyens J.M. Analgesic effects of several calcium channel blockers in mice. European Journal of Pharmacology 1987, 137:155-160.
9. Dogrul A., Yesilyurt O., Isimer A., Guzeldemir M.E. L-type and T-type calcium channel blockade potentiate the analgesic effects of morphine and selective mu opioid agonist, but not to selective delta and kappa agonist at the level of the spinal cord in mice. Pain 2001, 93:61-68.
10. Omote K., Sonoda H., Kawamata M., Iwasaki H., Namiki A. Potentiation of antinociceptive effects of morphine by calcium-channel blockers at the level of the spinal cord. Anesthesiology 1993, 79:746-752.
11. 2+ channels in attenuated morphine antinociception in streptozotocin-diabetic rats. European Journal of Pharmacology 2002, 435:187-194.
12. Gul H., Yildiz O., Dogrul A., Yesilyurt O., Isimer A. The interaction between IL-1beta and morphine: possible mechanism of the deficiency of morphine-induced analgesia in diabetic mice. Pain 2000, 89:39-45.
13. Ibironke G.F., Saba O.J. Effect of hyperglycemia on the efficacy of morphine analgesia in rats. African Journal of Medicine and Medical Sciences 2006, 35:443-445.
14. Karci A., Tasdogen A., Erkin Y., Aktas G., Elar Z. The analgesic effect of morphine on postoperative pain in diabetic patients. Acta Anaesthesiologica Scandinavica 2004, 48:619-624.
15. Biala G., Weglinska B. On the mechanism of cross-tolerance between morphine- and nicotine-induced antinociception: involvement of calcium channels. Progress in Neuropsychopharmacology & Biological Psychiatry 2006, 30:15-21.
16. Sukriti, Hota D., Pandhi P. Potentiation of antihyperalgesic activity of diclofenac by nimodipine in a formalin model of facial pain in rats. Methods and Findings in Experimental and Clinical Pharmacology 2004, 26:253-256.
17. Kamei J., Aoki T., Hitosugi H., Iwamoto Y., Kasuya Y. Effects of morphine on responses of nociceptive ventrobasal thalamic neurons in diabetic rats. Japanese Journal of Pharmacology 1992, 60:133-140.
18. Joharchi K.H., Jorjani M. Diabetes Increases the analgesia and tolerance to morphine in acute pain, but not in chronic pain while it attenuates the dependency in rats. International Journal of Endocrinology and Metabolism 2006, 136-146.
19. Simmons Z., Feldman E.L. Update on diabetic neuropathy. Current Opinion in Neurology 2002, 15:595-603.
20. Sounvoravong S., Nakashima M.N., Wada M., Nakashima K. Decrease in serotonin concentration in raphe magnus nucleus and attenuation of morphine analgesia in two mice models of neuropathic pain. European Journal of Pharmacology 2004, 484:217-223.
21. Voitenko N.V., Kruglikov I.A., Kostyuk E.P., Kostyuk P.G. Effect of streptozotocin-induced diabetes on the activity of calcium channels in rat dorsal horn neurons. Neuroscience 2000, 95:519-524.
22. Jolivalt C.G., Jiang Y., Freshwater J.D., Bartoszyk G.D., Calcutt N.A. Dynorphin A, kappa opioid receptors and the antinociceptive efficacy of asimadoline in streptozotocin-induced diabetic rats. Diabetologia 2006, 49:2775-2785.
23. + channel-acting drugs. British Journal of Pharmacology 1995, 114:1296-1302.
24. Ocana M., Del Pozo E., Barrios M., Robles L.I., Baeyens J.M. An ATP-dependent potassium channel blocker antagonizes morphine analgesia. European Journal of Pharmacology 1990, 186:377-378.
25. Wild K.D., Vanderah T., Mosberg H.I., Porreca F. Opioid delta receptor subtypes are associated with different potassium channels. European Journal of Pharmacology 1991, 193:135-136.
26. Kamei J., Kawashima N., Narita M., Suzuki T., Misawa M., Kasuya Y. Reduction in ATP-sensitive potassium channel-mediated antinociception in diabetic mice. Psychopharmacology (Berlin) 1994, 113:318-321.
27. Rashid M.H., Inoue M., Matsumoto M., Ueda H. Switching of bradykinin-mediated nociception following partial sciatic nerve injury in mice. Journal of Pharmacology and Experimental Therapeutics 2004, 308:1158-1164.
28. +(ATP) channel openers via interaction with morphine and an alpha(2)-adrenergic agonist in rats. Anesthesia and Analgesia 2000, 90:1146-1151.
29. Narita M., Suzuki T., Misawa M., Nagase H., Nabeshima A., Ashizawa T., et al. Role of central ATP-sensitive potassium channels in the analgesic effect and spinal noradrenaline turnover-enhancing effect of intracerebroventricularly injected morphine in mice. Brain Research 1992, 596:209-214.
30. Horvath G., Brodacz B., Holzer-Petsche U. Role of calcium channels in the spinal transmission of nociceptive information from the mesentery. Pain 2001, 93:35-41.
31. 2+ channel blockers. European Journal of Pharmacology 1992, 217:137-141.
32. Kumar R., Mehra R., Ray S.B. L-type calcium channel blockers, morphine and pain: Newer insights. Indian Journal of Anaesthesia 2010, 54:127-131.
33. 2+ channel antagonists on morphine analgesia, tolerance and dependence, and on blood pressure in the rat. European Journal of Pharmacology 1998, 352:189-197.
34. Zharkovsky A., Katajamaki J., Seppala T., Ahtee L. Morphine-induced analgesia in rats withdrawn from concurrent nimodipine and morphine treatment. Pain 1999, 79:217-222.
35. Shimizu N., Kishioka S., Maeda T., Fukazawa Y., Yamamoto C., Ozaki M., et al. Role of pharmacokinetic effects in the potentiation of morphine analgesia by L-type calcium channel blockers in mice. Journal of Pharmacological Sciences 2004, 94:240-245.